In a later publication using a tyrosine antibody array, several RTKs able to bind to PKM2 were detected, and their ability to phosphorylate PKM2 was confirmed when overexpressed in a breast cancer cell line (Axl, EpHA2, FAK, Tyro3, ErbB2, 29440169 [27]). The gene discussed is TYRO3; the disease is breast carcinoma.